CACaption Management, LLC
Institutional investor · Portfolio as of Q1 2021
Top Holdings992 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
WIX COM LTD | 352,900 | $98.5M | 2.1% | — | — | — | Increased — |
WAYFAIR INC- CLASS A | 305,305 | $96.1M | 2.1% | $151.79 | +108.85% | 5 qtrssince 2020-Q1 | Increased 61 |
BIOGEN IDEC INC | 301,000 | $84.2M | 1.8% | — | — | — | Increased — |
SPDR S&P BIOTECH ETF | 570,600 | $77.4M | 1.7% | — | — | — | New — |
KOHLS CORP | 1M | $62.4M | 1.3% | — | — | — | Increased — |
ADIENT PLC | 1.4M | $61.4M | 1.3% | — | — | — | Increased — |
ENPHASE ENERGY INC | 351,500 | $57M | 1.2% | — | — | — | Increased — |
APPLIED MATERIALS INC | 414,500 | $55.4M | 1.2% | — | — | — | Increased — |
| 237,500 | $50.1M | 1.1% | — | — | — | Increased — | |
PELOTON INTERACTIVE INC-A | 389,300 | $43.8M | 0.9% | — | — | — | Decreased — |
QUANTUMSCAPE CORP | 945,000 | $42.3M | 0.9% | — | — | — | New — |
TYLER TECHNOLOGIES INC | 90,000 | $38.2M | 0.8% | — | — | — | New — |
HORIZON THERAPEUTICS PLC | 413,500 | $38.1M | 0.8% | — | — | — | Increased — |
uniQure N.V. | 1.1M | $36.3M | 0.8% | — | — | — | Increased — |
HORIZON THERAPEUTICS PLC | 387,700 | $35.7M | 0.8% | — | — | — | Increased — |
MASTERCARD INC - A | 100,000 | $35.6M | 0.8% | — | — | — | New — |
ZENDESK INC | 250,000 | $33.2M | 0.7% | — | — | — | Increased — |
CHARTER COMMUNICATIONS INC - CLASS A | 50,000 | $30.9M | 0.7% | — | — | — | Unchanged — |
QUANTUMSCAPE CORP | 653,000 | $29.2M | 0.6% | — | — | — | New — |
CLEVELAND-CLIFFS INC | 1.4M | $29.2M | 0.6% | — | — | — | Increased — |
Caption Management, LLC manages $4.7B across 992 positions as of Q1 2021. Top holdings: WIX (2.1%), W (2.1%), BIIB (1.8%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1/5.0.
Active quarter - 240 new positions, 192 exits, 62 increased. Top move: W (INCREASED, conviction 61). Portfolio: $4.7B across 992 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer